Patrizia Giannatempo, Medical Oncology Consultant at the National Cancer Institute (INT) in Milan, shared a post on X:
Mind-blowing ASCOGU23 session!
Biomarker advancements are here.
Fragmentomics, epigenomic & transcriptomic liquid biopsies – the future of diagnosis & treatment is now.
